Tibet Aim Pharm

Tibet Aim Pharm Overview

Founded 2004
Status Public
Employees 421
Stock Symbol 002826
Stock Symbol
Share Price $1.60 (As of Friday Closing)

Tibet Aim Pharm General Information


Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 11F, CYTS Mansion, No.5
  • Dongzhimen Avenue, Dongcheng District
  • Beijing, 100007
  • China
+86 010 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tibet Aim Pharm Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.60 $1.58 $1.29 - $1.76 $309M 193M 3.63M $0.03

Tibet Aim Pharm Financials Summary

In Thousands,
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 264,884 275,047 275,011 414,483
Revenue 78,013 80,078 73,886 56,273
EBITDA 7,127 8,790 5,942 11,245
Net Income 5,273 5,403 3,818 8,949
Total Assets 108,259 119,398 110,181 112,318
Total Debt 0 10,005 5,815 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ready to get started?

Request a free trial